0.051
-0.01 (-15%)
0.055
+0 (+7.84%)
ChartMill assigns a Buy % Consensus number of 78% to GNCA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.14. This target is 6060% above the current price.
GNCA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about GNCA.
In the previous month the buy percentage consensus was at a similar level.
GNCA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-04-29 | Stifel | Downgrade | Buy -> Hold |
| 2022-04-29 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
| 2021-02-11 | Needham | Maintains | Buy |
GENOCEA BIOSCIENCES INC / GNCA FAQ
What is the price target for GNCA stock?
9 analysts have analysed GNCA and the average price target is 3.14 null. This implies a price increase of 6060% is expected in the next year compared to the current price of 0.051.
Can you provide the consensus rating for GENOCEA BIOSCIENCES INC stock?
The consensus rating for GENOCEA BIOSCIENCES INC (GNCA) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.